|Bid||79.200 x 0|
|Ask||79.250 x 0|
|Day's Range||78.600 - 80.100|
|52 Week Range||70.150 - 102.600|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||18.50|
|Earnings Date||Aug 15, 2022 - Aug 19, 2022|
|Forward Dividend & Yield||1.46 (1.84%)|
|Ex-Dividend Date||May 24, 2022|
|1y Target Est||104.71|
AXAHY, BGS, and AAGIY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2022.
AIA Group Ltd on Friday launched a $10 billion share buyback plan and declared a higher final dividend on strong growth in 2021, but warned of near-term pain from a recent outbreak of coronavirus infections in Hong Kong. The Asia-focussed insurer's value of new business or VONB, which measures expected profit from new premiums and is a key gauge for future growth, rose to $3.37 billion for the year ended Dec. 31, from $2.77 billion a year earlier. China and Hong Kong accounted for about half of new business growth globally.
AIA Group Limited (the "Company", and together with its subsidiaries, "AIA" or the "Group") announces that it has established a new pan-Asian Health InsurTech business called 'Amplify Health', encompassing a joint venture entity with Discovery Group Limited ("Discovery") for Asia excluding Mainland China, Hong Kong and Macau and a separate entity wholly owned by AIA for these three markets. The vision for Amplify Health is to be a leading digital health technology and integrated solutions busine